Inventor · disambiguated record
Franziska Elena Herrmann
Also filed as: HERRMANN FRANZISKA · HERRMANN FRANZISKA ELENA
3 granted patents·4 pending applications·0 citations·filing 2017–2025
52Inventor score
Files withBOEHRINGER INGELHEIM INT7
Top patents by PatentIndex Score
7 records- 0180US12233068B2Combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD)BOEHRINGER INGELHEIM INT·Filed 2023·Granted Feb 25, 2025·0 cites·6 claims
- 0275US11813266B2Combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD)BOEHRINGER INGELHEIM INT·Filed 2022·Granted Nov 14, 2023·0 cites·7 claims
- 0368US11406638B2Combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD)BOEHRINGER INGELHEIM INT·Filed 2018·Granted Aug 9, 2022·0 cites·10 claims
- 0467US2025241919A1Combination of active agents for the treatment of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)BOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 0562US2024142467A1Use of Biomarkers in the Treatment of Fibrotic Conditions with a PDE4B-inhibitorBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0657US2024401057A1Adamts14 inhibitionBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0739US2020069679A1Nintedanib for use in methods for the treatment of interstitial lung diseases by coadministration with oladaterolBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Franziska Elena Herrmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →